Key Takeaways Orforglipron becomes first oral GLP-1 receptor agonist to complete Phase 3 trial: Eli Lilly’s once-daily pill ...

Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Wellness startups are launching products that target the natural growth of GLP-1, the hormone that medicines like Ozempic and ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

A daily pill from Eli Lilly lowered blood sugar levels and induced weight loss in people with Type 2 diabetes, the company announced Thursday.

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

The results bring Eli Lilly’s pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.

New research suggests omega-3 may kill two birds with one stone by preventing two common and debilitating diseases ...

Learn the best times to take apple cider vinegar to enhance its health benefits, including weight loss and improved digestion ...

Nampa, April 15, 2025 (GLOBE NEWSWIRE) -- Best Diabetes Supplement of 2025: Learn How GlucoRedi Sets a New Benchmark in Wellness Industry Content Promoted By Branding EX Solution pvt ltd ( ...

Water-based protein shakes contain fewer calories, while milk-based protein shakes may benefit gym-goers more. However, both ...